Literature DB >> 35976447

Functional Approaches to the Surgery of Brain Gliomas.

Davide Giampiccolo1,2,3,4, Sonia Nunes1, Luigi Cattaneo5, Francesco Sala6.   

Abstract

In the surgery of gliomas, recent years have witnessed unprecedented theoretical and technical development, which extensively increased indication to surgery. On one hand, it has been solidly demonstrated the impact of gross total resection on life expectancy. On the other hand, the paradigm shift from classical cortical localization of brain function towards connectomics caused by the resurgence of awake surgery and the advent of tractography has permitted safer surgeries focused on subcortical white matter tracts preservation and allowed for surgical resections within regions, such as Broca's area or the primary motor cortex, which were previously deemed inoperable. Furthermore, new asleep electrophysiological techniques have been developed whenever awake surgery is not an option, such as operating in situations of poor compliance (including paediatric patients) or pre-existing neurological deficits. One such strategy is the use of intraoperative neurophysiological monitoring (IONM), enabling the identification and preservation of functionally defined, but anatomically ambiguous, cortico-subcortical structures through mapping and monitoring techniques. These advances tie in with novel challenges, specifically risk prediction and the impact of neuroplasticity, the indication for tumour resection beyond visible borders, or supratotal resection, and most of all, a reappraisal of the importance of the right hemisphere from early psychosurgery to mapping and preservation of social behaviour, executive control, and decision making.Here we review current advances and future perspectives in a functional approach to glioma surgery.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Brain mapping; Cortico-cortical-evoked potentials (CCEPs); Glioma surgery; Intraoperative neurophysiological monitoring (IONM); Motor-evoked potentials

Mesh:

Year:  2022        PMID: 35976447     DOI: 10.1007/978-3-030-99166-1_2

Source DB:  PubMed          Journal:  Adv Tech Stand Neurosurg        ISSN: 0095-4829


  215 in total

Review 1.  Genetic and molecular epidemiology of adult diffuse glioma.

Authors:  Annette M Molinaro; Jennie W Taylor; John K Wiencke; Margaret R Wrensch
Journal:  Nat Rev Neurol       Date:  2019-06-21       Impact factor: 42.937

2.  Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article.

Authors:  Laurent Capelle; Denys Fontaine; Emmanuel Mandonnet; Luc Taillandier; Jean Louis Golmard; Luc Bauchet; Johan Pallud; Philippe Peruzzi; Marie Hélène Baron; Michèle Kujas; Jacques Guyotat; Remi Guillevin; Marc Frenay; Sophie Taillibert; Philippe Colin; Valérie Rigau; Fanny Vandenbos; Catherine Pinelli; Hugues Duffau
Journal:  J Neurosurg       Date:  2013-03-15       Impact factor: 5.115

3.  Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas.

Authors:  J C Reijneveld; M M Sitskoorn; M Klein; J Nuyen; M J Taphoorn
Journal:  Neurology       Date:  2001-03-13       Impact factor: 9.910

4.  Suspected low-grade glioma: is deferring treatment safe?

Authors:  L D Recht; R Lew; T W Smith
Journal:  Ann Neurol       Date:  1992-04       Impact factor: 10.422

5.  An extent of resection threshold for newly diagnosed glioblastomas.

Authors:  Nader Sanai; Mei-Yin Polley; Michael W McDermott; Andrew T Parsa; Mitchel S Berger
Journal:  J Neurosurg       Date:  2011-03-18       Impact factor: 5.115

6.  A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.

Authors:  M Lacroix; D Abi-Said; D R Fourney; Z L Gokaslan; W Shi; F DeMonte; F F Lang; I E McCutcheon; S J Hassenbusch; E Holland; K Hess; C Michael; D Miller; R Sawaya
Journal:  J Neurosurg       Date:  2001-08       Impact factor: 5.115

7.  Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials.

Authors:  E T Wong; K R Hess; M J Gleason; K A Jaeckle; A P Kyritsis; M D Prados; V A Levin; W K Yung
Journal:  J Clin Oncol       Date:  1999-08       Impact factor: 44.544

Review 8.  The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults.

Authors:  J M Nazzaro; E A Neuwelt
Journal:  J Neurosurg       Date:  1990-09       Impact factor: 5.115

9.  The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma.

Authors:  Sasha Gulati; Asgeir S Jakola; Ulf S Nerland; Clemens Weber; Ole Solheim
Journal:  World Neurosurg       Date:  2011-12       Impact factor: 2.104

10.  Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up.

Authors:  Hugues Duffau
Journal:  Acta Neurochir (Wien)       Date:  2015-11-03       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.